CHECKPOINT THERAPEUTICS INC's ticker is CKPT and the CUSIP is 162828107. A total of 64 filers reported holding CHECKPOINT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $372,000 | -52.1% | 357,500 | -52.6% | 0.00% | 0.0% |
| Q2 2022 | $777,000 | -52.4% | 754,390 | -18.3% | 0.00% | -50.0% |
| Q1 2022 | $1,634,000 | +132.1% | 923,035 | +307.5% | 0.00% | +100.0% |
| Q4 2021 | $704,000 | +851.4% | 226,500 | +707.5% | 0.00% | – |
| Q4 2020 | $74,000 | -76.6% | 28,051 | -76.2% | 0.00% | – |
| Q3 2020 | $316,000 | +57.2% | 117,900 | +16.2% | 0.00% | – |
| Q2 2020 | $201,000 | +191.3% | 101,500 | +121.1% | 0.00% | – |
| Q1 2020 | $69,000 | -66.2% | 45,904 | -61.3% | 0.00% | – |
| Q4 2019 | $204,000 | -35.2% | 118,704 | -6.1% | 0.00% | – |
| Q3 2019 | $315,000 | -26.1% | 126,404 | -10.2% | 0.00% | – |
| Q2 2019 | $426,000 | +19.7% | 140,704 | +13.1% | 0.00% | – |
| Q1 2019 | $356,000 | +70.3% | 124,404 | +8.2% | 0.00% | – |
| Q4 2018 | $209,000 | -26.4% | 115,004 | +44.7% | 0.00% | – |
| Q3 2018 | $284,000 | – | 79,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 1,175,832 | $3,657,000 | 2.24% |
| PVG ASSET MANAGEMENT CORP | 80,307 | $249,754,000 | 0.91% |
| EMFO, LLC | 196,250 | $610,000 | 0.54% |
| Telemetry Investments, L.L.C. | 65,000 | $202,000 | 0.26% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 136,155 | $423,000 | 0.21% |
| Tatro Capital, LLC | 18,816 | $59,000 | 0.04% |
| Kepos Capital LP | 100,000 | $311,000 | 0.03% |
| EXANE DERIVATIVES | 31,262 | $97,221,000 | 0.02% |
| Golden State Equity Partners | 13,100 | $41,000 | 0.02% |
| Cordant, Inc. | 10,820 | $34,000 | 0.02% |